Industry Webinar: Redefining Heart Transplant Care – How Donor-Derived Cell-Free DNA is Transforming

This webinar is presented by Natera and will highlight how the innovations of dd-cfDNA and DQS improve detection of rejection, reduce reliance on invasive biopsies, and pave the way for more personalized patient management.

Attendees will gain first-hand insights into how dd-cfDNA testing—enhanced by a two-threshold approach—outperforms traditional surveillance, reduces false positives, and enables earlier, more accurate interventions to protect graft health and improve outcomes.

This webinar is free and open to all, but registration is required. View the program and register at ishlt.org.